Related Experiment Videos
Prevalence of drug-resistant tuberculosis in South Africa - Authors' reply
Nazir A Ismail1, Shaheed V Omar2, Lindiwe Mvusi3
1National Institute for Communicable Diseases, Johannesburg, South Africa; Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.
The Lancet. Infectious Diseases
|August 2, 2018
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Artificial intelligence can match domain experts in evidence extraction and critical appraisal of microbial oncogenesis research publications.
Frontiers in cellular and infection microbiology·2026
Correction: Artificial intelligence can match domain experts in evidence extraction and critical appraisal of microbial oncogenesis research publications.
Frontiers in cellular and infection microbiology·2026
A Plasma Metabolic Signature to Diagnose Pulmonary Tuberculosis and Monitor Treatment Response.
The Journal of infectious diseases·2025
A scoping review of interventions to address TB associated respiratory disability.
EClinicalMedicine·2024
When the fungus is susceptible, but the patient is not: reading antifungal susceptibility from bench to bedside.
The Lancet. Infectious diseases·2026
Evidence of artemisinin partial resistance in Zambia: a molecular epidemiology and clinical study.
The Lancet. Infectious diseases·2026
Immunogenicity and safety of BPZE1, an intranasal live attenuated pertussis vaccine, evaluated with and without tetanus-reduced diphtheria-acellular pertussis vaccine in healthy children aged 6-17 years: a randomised, active-controlled and placebo-controlled, phase 2b trial.
The Lancet. Infectious diseases·2026
Methodological quality and risk of bias in non-randomised comparative effectiveness studies of invasive mould infections: a systematic review.
The Lancet. Infectious diseases·2026
The risk of mpox false positive results in high transmission settings: evidence from a multi-site observational study in DR Congo.
The Lancet. Infectious diseases·2026
Comparison of antimicrobial susceptibility testing methods for aztreonam-avibactam against NDM-producing Enterobacterales clinical isolates.
Journal of clinical microbiology·2026
Male Partner Treatment for Bacterial Vaginosis: A Systematic Review and Meta-Analysis of Randomized Trials.
Sexually transmitted diseases·2026
Crystal structure of the bifunctional enzyme phosphoribosyl isomerase A from Mycobacterium tuberculosis with bound light-controllable inhibitor.
Acta crystallographica. Section F, Structural biology communications·2026
Eleven-Year Trends in Antimicrobial Resistance and Isolation Rates per 1000 Patient-Days of Key Gram-Positive and Gram-Negative Bacteria in a Tertiary Care Hospital in Türkiye (2014-2024).
Infectious diseases & clinical microbiology·2026